Immuneering Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Immuneering Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Immuneering Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$14.6M, a 15.9% decline year-over-year.
  • Immuneering Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$58.1M, a 12.5% decline year-over-year.
  • Immuneering Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$53.5M, a 5.86% decline from 2022.
  • Immuneering Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$50.5M, a 50.6% decline from 2021.
  • Immuneering Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$33.5M, a 96.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$58.1M -$14.6M -$2M -15.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$56.1M -$14.1M -$1.89M -15.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$54.2M -$14.3M -$704K -5.17% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$53.5M -$15.1M -$1.84M -13.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 -$51.6M -$12.6M +$249K +1.94% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$51.9M -$12.2M -$661K -5.74% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$51.2M -$13.6M -$708K -5.49% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$50.5M -$13.2M -$2.46M -22.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 -$48.1M -$12.8M -$4.31M -50.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$43.7M -$11.5M -$3.54M -44.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$40.2M -$12.9M -$6.67M -107% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$33.5M -$10.8M -$4.95M -84.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$28.6M -$8.53M -$4.13M -94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$24.5M -$7.99M -$4.38M -122% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$20.1M -$6.23M -$3.03M -94.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$17M -$5.84M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$4.4M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$3.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$3.2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.